IP Library › Patent Application 18736608
Patent Application
App. No. 18/736,608

SEMAGLUTIDE IN MEDICAL THERAPY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/736,608
Abstract

The present invention relates to semaglutide for use in weight management.

Claims (13)

1 . A method for reducing body weight of a subject in need thereof, comprising administering semaglutide to the subject in an amount of about 2.0-10.0 mg once weekly.

2 . The method according to claim 1 , wherein the semaglutide is administered subcutaneously.

3 . The method according to claim 1 , wherein the subject is overweight.

4 . The method according to claim 1 , wherein the subject suffers from obesity.

5 . The method according to claim 1 , wherein the subject has at least one weight-related comorbid condition selected from the group consisting of hypertension, type 2 diabetes mellitus, dyslipidemia, sleep apnoea, and urine incontinence.

6 . The method according to claim 5 , wherein the subject has type 2 diabetes mellitus.

7 . A method for reducing body weight of a subject in need thereof, comprising administering semaglutide to the subject in an amount of 2.0-10.0 mg once weekly.

8 . The method according to claim 7 , wherein the semaglutide is administered once weekly.

9 . The method according to claim 8 , wherein the semaglutide is administering subcutaneously.

10 . The method according to claim 9 , wherein the subject is overweight.

11 . The method according to claim 10 , wherein the subject has type 2 diabetes mellitus.

12 . The method according to claim 9 , wherein the subject is suffering from obesity.

13 . The method according to claim 12 , wherein the subject has type 2 diabetes mellitus.